Monitoring of lipodystrophic and metabolic abnormalities in HIV-1 infected children on antiretroviral therapy

Vana Spoulou; Christina Kanaka‐Gantenbein; Irini Bathrellou; Stefano Mora; Glyceria Mostrou; Labros S. Sidossis; George Chrousos; Maria Theodoridou

doi:10.14310/horm.2002.1305

Related publications

Article1998

Maintenance Antiretroviral Therapies in HIV-Infected Subjects with Undetectable Plasma HIV RNA after Triple-Drug Therapy

Diane V. Havlir, Ian C. Marschner, Martin Hirsch, Ann C. Collier, Pablo Tebas, Roland L. Bassett, John P A Ioannidis, M. K. Holohan, Randi Y. Leavitt, Gloria S. Boone, Douglas D. Richman

Article2001

Prevalence of Genotypic Resistance among Antiretroviral Drug-Naive HIV-1-Infected Patients in Belgium

Kristien Van Vaerenbergh, Laurent Debaisieux, Nancy De Cabooter, Cathérine Declercq, K. Desmet, Katrien Fransen, Bart Maes, D. Marissens, Katherine M. Miller, Gaëtan Muyldermans, S Sprecher, Lieven Stuyver, D. Vaira, Chris Verhofstede, Georges Zissis, Marc Van Ranst, De Clercq Erik, Jan Desmyter, Anne‐Mieke Vandamme

Article2001

Virologic and Immunologic Consequences of Discontinuing Combination Antiretroviral-Drug Therapy in HIV-Infected Patients with Detectable Viremia

Steven G. Deeks, Terri Wrin, Teri Liegler, Rebecca Hoh, Matthew S. Hayden, Jason D. Barbour, Nicholas S. Hellmann, Christos J. Petropoulos, Joseph M. McCune, Marc Hellerstein, Robert M. Grant

Article2007

Recombination favors the evolution of drug resistance in HIV-1 during antiretroviral therapy

Antonio Carvajal‐Rodríguez, Keith A. Crandall, David Posada

Article2001

HIV-1 Integration as a Target for Antiretroviral Therapy: A Review

Wim Pluymers, De Clercq Erik, Zeger Debyser

Monitoring of lipodystrophic and metabolic abnormalities in HIV-1 infected children on antiretroviral therapy

Discussion(0)

Related publications

Maintenance Antiretroviral Therapies in HIV-Infected Subjects with Undetectable Plasma HIV RNA after Triple-Drug Therapy

Prevalence of Genotypic Resistance among Antiretroviral Drug-Naive HIV-1-Infected Patients in Belgium

Virologic and Immunologic Consequences of Discontinuing Combination Antiretroviral-Drug Therapy in HIV-Infected Patients with Detectable Viremia

Recombination favors the evolution of drug resistance in HIV-1 during antiretroviral therapy

HIV-1 Integration as a Target for Antiretroviral Therapy: A Review